Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R R Edwards

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Osteoarthritis and Cartilage|November 10, 2020
Cost-effectiveness of duloxetine for knee OA subjects: the role of pain severityJ K Sullivan, J Huizinga, R R Edwards, et al.
Pain Medicine (Malden, Mass.)|March 3, 2016
Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative AffectR R Edwards, A J Dolman, E Michna, et al.
Osteoarthritis and Cartilage|November 22, 2022
Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysisG P Bensen, A C Rogers, V P Leifer, et al.
Molecular Psychiatry|May 30, 2019
The neuroinflammatory component of negative affect in patients with chronic painD S Albrecht, M Kim, O Akeju, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Osteoarthritis and Cartilage|November 10, 2020
Cost-effectiveness of duloxetine for knee OA subjects: the role of pain severityJ K Sullivan, J Huizinga, R R Edwards, et al.
Pain Medicine (Malden, Mass.)|March 3, 2016
Changes in Pain Sensitivity and Pain Modulation During Oral Opioid Treatment: The Impact of Negative AffectR R Edwards, A J Dolman, E Michna, et al.
Osteoarthritis and Cartilage|November 22, 2022
Does gabapentin provide benefit for patients with knee OA? A benefit-harm and cost-effectiveness analysisG P Bensen, A C Rogers, V P Leifer, et al.
Molecular Psychiatry|May 30, 2019
The neuroinflammatory component of negative affect in patients with chronic painD S Albrecht, M Kim, O Akeju, et al.
Pageof 3